The research activities are conducted to find alternatives to conventional animal-based toxicity testing such as in vitro toxicology assays thatare complemented by in silico and in chemico testing procedures. The metabolic, toxicokinetic, and bioanalytical research is supported by the in vitro toxicity testing services. The establishment of tools for in vitro toxicity assessment, which offers test systems and data required for the development of computer modelling tools for topics like system biology and physiologically based modelling, is a crucial part of this aim. A human cell and organoid-based in vitro technique is becoming increasingly popular for chemical toxicity assessment for a variety of factors including scientific relevance, effectiveness, affordability, and moral propriety.

Market Dynamics                                               

Major players in the market are focused on the research and development activities, and thu,s it is expected to drive the market growth in near future. For instance, on June 21, 2021, a revised test guideline for the fish cell line acute toxicity assay was approved at the 33rd Meeting of the OECD Working Group of the National Coordinators, Austria for the Test Guidelines Programme in April 2021, and it had been published by the International Council on Animal Protection in OECD Programmes (ICAPO). Numerous studies have demonstrated how effectively the assay can forecast acute toxicity to fish for a wide range of chemicals when carried out in compliance with OECD test guidelines. Therefore, by including this assay into a weight of evidence or integrated approach to testing and assessment (IATA) for acute fish toxicity assessment, it has the potential to replace acute fish toxicity testing in a significant way.

Key features of the study:

• This report provides an in-depth analysis of the global in vitro toxicity testing market, and provides market size and compound annual growth rate for the forecast period (2023–2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global in vitro toxicity testing market based on the following parameters,company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Bio-Rad Laboratories, Inc., Cyprotex, Covance Inc., LifeNet Health LifeSciences , Creative Bioarray, Charles River Laboratories, Intertek Group plc, LGC Limited, SGS Société Générale de Surveillance SA, Preferred Cell Systems, Microbac Laboratories, Inc., Eurofins Discovery, Creative Biolabs, LAUS GmbH, and Vimta Labs Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global in vitro toxicity testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global in vitro toxicity testing market

Detailed Segmentation:

• Global In Vitro Toxicity Testing Market, By Type:
  • Absorption
  • Toxic Substances
  • Dose
• Global In Vitro Toxicity Testing Market, By End User:
  • Cosmetics Industry
  • Pharmaceutical Industry
  • Food Industry
  • Chemicals Industry
• Global In Vitro Toxicity Testing Market, By Region:
  • North America
    
    • U.S.
    • Canada
  • Latin America
    
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East :
    
    • GCC
    • Israel
    • Rest of Middle East
  • Africa :
    
    • South Africa
    • Central Africa
    • North Africa
• Company Profiles
  • Bio-Rad Laboratories, Inc.
  • Cyprotex
  • Covance Inc.
  • LifeNet Health LifeSciences
  • Creative Bioarray
  • Charles River Laboratories
  • Intertek Group plc
  • LGC Limited
  • SGS Société Générale de Surveillance SA
  • Preferred Cell Systems
  • Microbac Laboratories, Inc.
  • Eurofins Discovery
  • Creative Biolabs
  • LAUS GmbH
  • Vimta Labs Ltd.